Walgreens Boots Alliance Inc (WBA) : Cim scooped up 1,702 additional shares in Walgreens Boots Alliance Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 17, 2016. The investment management firm now holds a total of 104,355 shares of Walgreens Boots Alliance Inc which is valued at $8,172,040.Walgreens Boots Alliance Inc makes up approximately 3.90% of Cim’s portfolio.
Other Hedge Funds, Including , American National Bank reduced its stake in WBA by selling 3,366 shares or 7.37% in the most recent quarter. The Hedge Fund company now holds 42,329 shares of WBA which is valued at $3,314,784. Walgreens Boots Alliance Inc makes up approx 1.12% of American National Bank’s portfolio.Investment Management Of Virginia boosted its stake in WBA in the latest quarter, The investment management firm added 40 additional shares and now holds a total of 25,120 shares of Walgreens Boots Alliance Inc which is valued at $1,964,384. Walgreens Boots Alliance Inc makes up approx 0.50% of Investment Management Of Virginia’s portfolio.Headinvest reduced its stake in WBA by selling 885 shares or 4.16% in the most recent quarter. The Hedge Fund company now holds 20,375 shares of WBA which is valued at $1,622,869. Walgreens Boots Alliance Inc makes up approx 0.58% of Headinvest’s portfolio.Arvest Bank Trust Division reduced its stake in WBA by selling 454 shares or 0.48% in the most recent quarter. The Hedge Fund company now holds 94,497 shares of WBA which is valued at $7,548,420. Walgreens Boots Alliance Inc makes up approx 0.64% of Arvest Bank Trust Division’s portfolio.
Walgreens Boots Alliance Inc opened for trading at $78.43 and hit $78.69 on the upside on Friday, eventually ending the session at $78.31, with a gain of 0.14% or 0.11 points. The heightened volatility saw the trading volume jump to 26,57,834 shares. Company has a market cap of $84,756 M.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.
Investors should note that on Oct 12, 2016, Walgreens Boots Alliance Inc announced a cash dividend of $0.3750. The company’s management has announced Nov 15, 2016 as the ex-dividend date and fixed the record date on Nov 17, 2016. The payable date has been fixed on Dec 12, 2016.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Walgreens Boots Alliance Inc was Upgraded by Jefferies to ” Buy” on Oct 17, 2016. Company shares were Reiterated by Deutsche Bank on Aug 30, 2016 to “Buy”, Firm has raised the Price Target to $ 94 from a previous price target of $93 .
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.